• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection.

作者信息

Chang De, Mo Guoxin, Yuan Xin, Tao Yi, Peng Xiaohua, Wang Fu-Sheng, Xie Lixin, Sharma Lokesh, Dela Cruz Charles S, Qin Enqiang

机构信息

Chinese People's Liberation Army General HospitalBeijing, Chinaand.

Yale University School of MedicineNew Haven, Connecticut.

出版信息

Am J Respir Crit Care Med. 2020 May 1;201(9):1150-1152. doi: 10.1164/rccm.202003-0524LE.

DOI:10.1164/rccm.202003-0524LE
PMID:32200654
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7193851/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961a/7193851/451daf28b849/rccm.202003-0524LE_f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961a/7193851/451daf28b849/rccm.202003-0524LE_f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961a/7193851/451daf28b849/rccm.202003-0524LE_f1.jpg

相似文献

1
Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection.新型冠状病毒感染中病毒清除的时间动力学及症状消退情况
Am J Respir Crit Care Med. 2020 May 1;201(9):1150-1152. doi: 10.1164/rccm.202003-0524LE.
2
[COVID-19: Swiftness and solidarity].[新冠疫情：迅速行动与团结协作]
Laeknabladid. 2020 Jun;106(6):289. doi: 10.17992/lbl.2020.06.583.
3
Characteristics of Children With Reactivation of SARS-CoV-2 Infection After Hospital Discharge.出院后新冠病毒感染复阳儿童的特征
Clin Pediatr (Phila). 2020 Sep;59(9-10):929-932. doi: 10.1177/0009922820928057. Epub 2020 May 28.
4
SARS-Cov-2 (human) and COVID-19: Primer 2020.严重急性呼吸综合征冠状病毒2（人类）与冠状病毒病2019：2020年入门指南
Hepatol Int. 2020 Jul;14(4):475-477. doi: 10.1007/s12072-020-10049-7. Epub 2020 Apr 24.
5
Lessons unfolding from pediatric cases of COVID-19 disease caused by SARS-CoV-2 infection.由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染引起的儿童冠状病毒病（COVID-19）病例所呈现出的经验教训。
Pediatr Pulmonol. 2020 May;55(5):1085-1086. doi: 10.1002/ppul.24748. Epub 2020 Apr 3.
6
Pediatric Characteristics of 2019 Novel Coronavirus: Review of Available Published Literature.2019新型冠状病毒的儿科特征：现有已发表文献综述
Clin Pediatr (Phila). 2020 Sep;59(9-10):849-852. doi: 10.1177/0009922820920017. Epub 2020 Apr 15.
7
Triage of patients with COVID-19.新型冠状病毒肺炎患者的分诊
Br J Gen Pract. 2020 Jun 25;70(696):327. doi: 10.3399/bjgp20X710825. Print 2020 Jul.
8
Symptom Profiles and Risk Factors for Hospitalization in Patients With SARS-CoV-2 and COVID-19: A Large Cohort From South America.新型冠状病毒和新冠肺炎患者住院的症状特征及风险因素：来自南美的一个大型队列研究
Gastroenterology. 2020 Sep;159(3):1148-1150. doi: 10.1053/j.gastro.2020.05.014. Epub 2020 May 8.
9
Benign course of SARS-CoV-2 infection in a series of pediatric oncology patients.一系列儿科肿瘤患者中新型冠状病毒2型感染的良性病程
Pediatr Blood Cancer. 2020 Sep;67(9):e28504. doi: 10.1002/pbc.28504. Epub 2020 Jun 23.
10
SARS-CoV-2 infection in ambulatory and hospitalised Spanish children.西班牙门诊及住院儿童的新型冠状病毒2型感染情况
Arch Dis Child. 2020 Aug;105(8):808-809. doi: 10.1136/archdischild-2020-319366. Epub 2020 May 22.

引用本文的文献

1
Delayed Viral Clearance Accompanied by Early Impaired Humoral and Virus-Specific T-Cell Response in Patients with Coronavirus Disease 2019 and Interstitial Lung Disease.2019冠状病毒病合并间质性肺疾病患者病毒清除延迟，伴有早期体液免疫和病毒特异性T细胞反应受损
Vaccines (Basel). 2025 Jun 19;13(6):655. doi: 10.3390/vaccines13060655.
2
Median duration and factors that influence the duration of symptom resolution in COVID-19 patients in Ethiopia: A follow-up study involving symptomatic cases.埃塞俄比亚新冠肺炎患者症状缓解的中位持续时间及影响因素：一项针对有症状病例的随访研究
Lifestyle Med (Hoboken). 2021 Oct;2(4):e46. doi: 10.1002/lim2.46. Epub 2021 Aug 21.
3

本文引用的文献

1
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
2
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.新加坡 2019 年新型冠状病毒肺炎患者的流行病学特征和临床病程
JAMA. 2020 Apr 21;323(15):1488-1494. doi: 10.1001/jama.2020.3204.
3
Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China.
High SARS-CoV-2 tropism and activation of immune cells in the testes of non-vaccinated deceased COVID-19 patients.
未接种疫苗的 COVID-19 死亡患者睾丸中高 SARS-CoV-2 嗜性和免疫细胞的激活。
BMC Biol. 2023 Feb 16;21(1):36. doi: 10.1186/s12915-022-01497-8.
4
Bioinformatics insights into the genes and pathways on severe COVID-19 pathology in patients with comorbidities.对合并症患者中重症 COVID-19 病理学相关基因和通路的生物信息学见解。
Front Physiol. 2022 Dec 14;13:1045469. doi: 10.3389/fphys.2022.1045469. eCollection 2022.
5
Clinical predictors and RT-PCR profile of prolonged viral shedding in patients with SARS-CoV-2 Omicron variant in Shanghai: A retrospective observational study.上海 SARS-CoV-2 奥密克戎变异株患者病毒持续排出的临床预测因素和 RT-PCR 特征：一项回顾性观察研究。
Front Public Health. 2022 Oct 24;10:1015811. doi: 10.3389/fpubh.2022.1015811. eCollection 2022.
6
The Effect of Nitazoxanide on the Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.硝唑尼特对 COVID-19 患者临床结局的影响：一项随机对照试验的系统评价和荟萃分析。
Clin Drug Investig. 2022 Dec;42(12):1031-1047. doi: 10.1007/s40261-022-01213-y. Epub 2022 Oct 31.
7
Knowledge, attitude and preparedness to combat COVID-19 infection among dental professionals: A student-centric pilot study.牙科专业人员对新冠病毒感染的认知、态度及应对准备：一项以学生为中心的试点研究。
J Oral Maxillofac Pathol. 2022 Apr-Jun;26(2):179-184. doi: 10.4103/jomfp.jomfp_431_21. Epub 2022 Jun 28.
8
Controlling SARS-CoV-2 in schools using repetitive testing strategies.利用重复检测策略控制学校中的 SARS-CoV-2。
Elife. 2022 Jul 5;11:e75593. doi: 10.7554/eLife.75593.
9
Comprehensive Analysis of Disease Pathology in Immunocompetent and Immunocompromised Hosts following Pulmonary SARS-CoV-2 Infection.免疫功能正常和免疫功能低下宿主肺部感染SARS-CoV-2后的疾病病理学综合分析
Biomedicines. 2022 Jun 7;10(6):1343. doi: 10.3390/biomedicines10061343.
10
Single Dose of Ivermectin is not Useful in Patients with Hematological Disorders and COVID-19 Illness: A Phase II B Open Labelled Randomized Controlled Trial.单剂量伊维菌素对血液系统疾病合并新冠病毒疾病患者无效：一项II B期开放标签随机对照试验
Indian J Hematol Blood Transfus. 2022 Oct;38(4):615-622. doi: 10.1007/s12288-022-01546-w. Epub 2022 May 27.
中国 1 岁以下住院婴儿的新型冠状病毒感染。
JAMA. 2020 Apr 7;323(13):1313-1314. doi: 10.1001/jama.2020.2131.
4
Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China.中国武汉以外地区 13 例新型冠状病毒感染的流行病学和临床特征。
JAMA. 2020 Mar 17;323(11):1092-1093. doi: 10.1001/jama.2020.1623.
5
Novel Wuhan (2019-nCoV) Coronavirus.新型武汉（2019 - 新型冠状病毒）冠状病毒。
Am J Respir Crit Care Med. 2020 Feb 15;201(4):P7-P8. doi: 10.1164/rccm.2014P7.
6
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.德国一名无症状接触者传播2019新型冠状病毒感染
N Engl J Med. 2020 Mar 5;382(10):970-971. doi: 10.1056/NEJMc2001468. Epub 2020 Jan 30.
7
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.新型冠状病毒感染肺炎在中国武汉的早期传播动力学。
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses.冠状病毒的流行病学、基因重组与发病机制
Trends Microbiol. 2016 Jun;24(6):490-502. doi: 10.1016/j.tim.2016.03.003. Epub 2016 Mar 21.